Nature of Cardiac Rehabilitation Around the Globe.

Clicks: 400
ID: 45448
2019
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Cardiac rehabilitation (CR) is a clinically-effective but complex model of care. The purpose of this study was to characterize the nature of CR programs around the world, in relation to guideline recommendations, and compare this by World Health Organization (WHO) region.In this cross-sectional study, a piloted survey was administered online to CR programs globally. Cardiac associations and local champions facilitated program identification. Quality (benchmark of ≥ 75% of programs in a given country meeting each of 20 indicators) was ranked. Results were compared by WHO region using generalized linear mixed models.111/203 (54.7%) countries in the world offer CR; data were collected in 93 (83.8%; N = 1082 surveys, 32.1% program response rate). The most commonly-accepted indications were: myocardial infarction (n = 832, 97.4%), percutaneous coronary intervention (n = 820, 96.1%; 0.10), and coronary artery bypass surgery (n = 817, 95.8%). Most programs were led by physicians (n = 680; 69.1%). The most common CR providers (mean = 5.9 ± 2.8/program) were: nurses (n = 816, 88.1%; low in Africa, p < 0.001), dietitians (n = 739, 80.2%), and physiotherapists (n = 733, 79.3%). The most commonly-offered core components (mean = 8.7 ± 1.9 program) were: initial assessment (n = 939, 98.8%; most commonly for hypertension, tobacco, and physical inactivity), risk factor management (n = 928, 98.2%), patient education (n = 895, 96.9%), and exercise (n = 898, 94.3%; lower in Western Pacific, p < 0.01). All regions met ≥ 16/20 quality indicators, but quality was < 75% for tobacco cessation and return-to-work counseling (lower in Americas, p = < 0.05).This first-ever survey of CR around the globe suggests CR quality is high. However, there is significant regional variation, which could impact patient outcomes.
Reference Key
supervia2019natureeclinicalmedicine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Supervia, Marta;Turk-Adawi, Karam;Lopez-Jimenez, Francisco;Pesah, Ella;Ding, Rongjing;Britto, Raquel R;Bjarnason-Wehrens, Birna;Derman, Wayne;Abreu, Ana;Babu, Abraham S;Santos, Claudia Anchique;Jong, Seng K;Cuenza, Lucky;Yeo, Tee Joo;Scantlebury, Dawn;Andersen, Karl;Gonzalez, Graciela;Giga, Vojislav;Vulic, Dusko;Vataman, Eleonora;Cliff, Jacqueline;Kouidi, Evangelia;Yagci, Ilker;Kim, Chul;Benaim, Briseida;Estany, Eduardo Rivas;Fernandez, Rosalia;Radi, Basuni;Gaita, Dan;Simon, Attila;Chen, Ssu-Yuan;Roxburgh, Brendon;Martin, Juan Castillo;Maskhulia, Lela;Burdiat, Gerard;Salmon, Richard;Lomelí, Hermes;Sadeghi, Masoumeh;Sovova, Eliska;Hautala, Arto;Tamuleviciute-Prasciene, Egle;Ambrosetti, Marco;Neubeck, Lis;Asher, Elad;Kemps, Hareld;Eysymontt, Zbigniew;Farsky, Stefan;Hayward, Jo;Prescott, Eva;Dawkes, Susan;Santibanez, Claudio;Zeballos, Cecilia;Pavy, Bruno;Kiessling, Anna;Sarrafzadegan, Nizal;Baer, Carolyn;Thomas, Randal;Hu, Dayi;Grace, Sherry L;
Journal eclinicalmedicine
Year 2019
DOI
10.1016/j.eclinm.2019.06.006
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.